pharmaphorum

MARCH 15, 2022

During the first half of 2020, surveys indicated that doctors would be reluctant to attend physical meetings in 2021, indicating preferences based mainly on fear of contracting COVID-19 and availability of vaccines. yes, if vaccines are available; 15.8% The ‘hybrid’ label is confusing. Results from 335 responses were: 47.8%

Labelling 105

Labelling Vaccines Communication 105

The Checkup by Singlecare

SEPTEMBER 13, 2024

Choosing between Fasenra and Nucala to manage severe asthma requires complex decision-making and communication with your healthcare provider, but having an understanding of how the drugs work can help you understand why they may prescribe one over the other. Infection risk is also a worry, particularly parasitic infections.

Labelling 52

Labelling Insurance Immunization Insurance Coverage 52

The Checkup by Singlecare

MARCH 16, 2023

Department of Health & Human Services (HHS) expanded pharmacy technicians roles to include administering vaccines and point-of-care testing during the COVID-19 pandemic. That legislation has stuck since then, and it has received a positive response from the pharmacy community. RELATED: Ways to prevent common pharmacy errors 7.

Data Entry 52

Data Entry Long-Term Care Facilities Insurance Immunization 52

Hospital Pharmacy Europe

MARCH 13, 2025

Timely follow-up after hospital attendance and communication at transfers of care is therefore imperative Identifying patients through targeted searching of primary care databases is expected to be a way to review prescribing and revisit diagnosis.

Hospitals 52

Hospitals Communication Labelling Patient Care 52

Pharmaceutical Technology

JANUARY 5, 2023

The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The pharmaceutical industry has long been labelled as a recession-proof—stable demand for medicines and new treatment options acts as a protective barrier.

Vaccines 69

Vaccines Communication Labelling 69

Pharmaceutical Technology

MAY 25, 2023

The ongoing Phase 1/2a ( NCT04725331 ) study is a multicentre, open label, dose-escalation trial evaluating BT-001 as a single agent and in combination with the anti-PD-1 treatment, Keytruda. Keytruda for the trial is provided by MSD (Merck & Co). The Phase I is divided into two parts. Please check your email to download the Report.

Communication 52

Communication Labelling Vaccines 52

Pharmaceutical Technology

MARCH 21, 2023

A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure. The vaccine ACI-24.060 elicited an anti-Abeta antibody response in the first patient cohort after six weeks, as per the results. Please check your email to download the Report.

Packaging 59

Packaging FDA Vaccines Communication 59

ISPE

AUGUST 30, 2022

During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. You may unsubscribe from these ISPE communications at any time.

Documentation 52

Documentation FDA Packaging Communication 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 97

Immunization Vaccines Communication Labelling 97

Digital Pharmacist

AUGUST 28, 2023

Increase pharmacy revenue and help your patients prepare for flu season each year by continuously improving your vaccination program. Whether you’re just getting started or are looking to scale, here are some tips to help you generate more immunization revenue with a vaccination program. Here’s how to get started.

Immunization 98

Immunization Vaccines Communication Labelling 98

pharmaphorum

FEBRUARY 26, 2021

Robert Wood’s granddaughter, Mary Lea, was the first baby to be used on the baby powder label. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government.

Vaccines 126

Vaccines Communication Labelling 126

The Checkup by Singlecare

MARCH 28, 2024

It may also be prescribed off-label to treat other bacterial infections, including certain STDs. This can be done in several ways, including abstaining from sexual activity, vaccination, and mutual monogamy. Read on to learn more about treating STDs with amoxicillin. Can amoxicillin treat STDs?

Dosage 97

Dosage FDA Communication Labelling 97

Pharmaceutical Technology

MAY 24, 2023

This includes giving CMS the power to suspend the National Drug Rebate Agreement of a labeller for less than 30 days in case of late reporting of required drug and price information. Additionally, the HHS is seeking to improve the transparency of some of the costs that come with drug benefits in Medicaid-managed care plans.

Vaccines 52

Vaccines Communication Labelling 52

PharmaShots

APRIL 3, 2023

of the newly combined company The combined companies’ focus is to advance Elicio’s lymph node-targeting amphiphile technology to develop immunotherapies & also focus on ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors is currently being evaluated in the P-I trial (AMPLIFY-201) for PDAC and CRC.

FDA 40

FDA Compounding Hospitals Vaccines 40

pharmaphorum

AUGUST 27, 2020

Bioindustry association MichBio says the FDA’s labelling requirements for COVID-19 convalescent plasma (CCP) – which were published alongside the emergency use authorisation – could lead to “hundreds, if not thousands, of in-date, ready to transfuse CCP units across the country being rendered unusable.”. The @CDCgov was muzzled months ago.

FDA 105

FDA Mayo Clinic Labelling Communication 105

Hospital Pharmacy Europe

MARCH 13, 2025

Timely follow-up after hospital attendance and communication at transfers of care is therefore imperative Identifying patients through targeted searching of primary care databases is expected to be a way to review prescribing and revisit diagnosis.

Hospitals 52

Hospitals Communication Labelling Patient Care 52